The Centre for Applied Genomics (TCAG) at the Hospital for Sick Children in Toronto has reeled in C$5.1 million (US$5 million) from the Ontario Genomics Institute to support its operations, OGI said today.
Researchers from the Genome Institute of Singapore and elsewhere used a genome-wide RNA interference screen to find previously undetected genes involved in human embryonic stem cell regulatory networks.
The CNV assays are the latest effort by NanoString to ferret out new applications for its nCounter platform, which the company initially developed as an alternative to both qPCR and microarrays for gene expression studies.
The studies surmise that multiplex PCR respiratory virus assays, such as those offered by EraGen, Seegene, Luminex, and Qiagen, perform as well or better than traditional fluorescent antibody tagging and cell culture methods at detecting respiratory viruses in clinical specimens.
The company's most recent deal to apply its technology for assay development is "part of a broad program we have embarked on to exploit our unique ability to apply mass spectrometry to FFPE tissue," a company official said.